Biofactors in the Mediterranean diet

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 8, 2003, Pages 999-1004

  Gerber, Mariette ^a  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

Biofactors; Chronic degenerative diseases; Mediterranean diet; Phyto microconstituents; Vitamins

Indexed keywords

ALLYL COMPOUND; ALPHA CAROTENE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CALCIUM; CAROTENOID; CRYPTOXANTHIN; CYANOCOBALAMIN; FLAVONOL DERIVATIVE; FOLIC ACID; FOLIC ACID DERIVATIVE; GLUCOSINOLATE; INDOLE DERIVATIVE; ISOFLAVONE DERIVATIVE; ISOTHIOCYANIC ACID DERIVATIVE; LIGNAN DERIVATIVE; MINERAL; PHENOL DERIVATIVE; PHYTOESTROGEN; POTASSIUM; PYRIDOXINE; RETINOL; SELENIUM; TERPENE DERIVATIVE; THIAMINE; TRACE ELEMENT; UNINDEXED DRUG; VITAMIN; VITAMIN B GROUP;

ALPHA TOCOPHEROL DEFICIENCY; ANIMAL FOOD; ANTIOXIDANT ACTIVITY; ASCORBIC ACID DEFICIENCY; CANCER PREVENTION; CELL FUNCTION; CHRONIC DISEASE; DEGENERATIVE DISEASE; DEVELOPING COUNTRY; DIETARY INTAKE; DRUG MECHANISM; ENZYME ACTIVITY; FOOD COMPOSITION; HUMAN; MORTALITY; NUTRITIONAL VALUE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SOLUBILITY; SOUTHERN EUROPE; VITAMIN DEFICIENCY;

ALLYL COMPOUNDS; CARDIOVASCULAR DISEASES; CAROTENOIDS; DIET, MEDITERRANEAN; DISULFIDES; GLUCOSINOLATES; HUMANS; ISOFLAVONES; MICRONUTRIENTS; MINERALS; MODELS, BIOLOGICAL; NEOPLASMS; PHENOLS; PHYTOESTROGENS; PLANT PREPARATIONS; TERPENES; VITAMINS;

ANIMALIA;

EID: 0042354177     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.153     Document Type: Review

References (46)

1. Kushi LH, Lenart EB, Willett WC. Health implications of Mediterranean diets in light of contemporary knowledge. 1. Plant foods and dairy products. 2. Meats, wine, fats, and oils. Am J Clin Nutr 1995; 61:S1407-S27.
2. Gerber M. Health benefits of the Mediterranean diet model. In: Agropolis, editor. Mediterranean diet and health. Current news and prospects. Paris: John Libbey, 2001:3-50.
3. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, et al. Association between α-tocopherol, γ-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 2000; 92:2018-23.
4. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. J Am Med Assoc 1995; 274:1049-57.
5. Rohan TE, Jain MG, Howe GR, Miller AB. Dietary folate consumption and breast cancer risk. J Natl Cancer Inst 2000; 92:266-9.
6. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57:1098-102.
7. Gerber M, Amiot MJ, Offord E, Rock E. Relationship between tomatoes and their constituents, and diseases. In: Bilton R, Gerber M, Grolier P, Leoni C, editors. The White book on antioxidants in tomatoes and tomato products and their health benefits. A European Commission concerted action programme Fair CT 97-3233. Avignon, France: CMITI Sarl, 2001:Chapter 3:1-93.
8. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Menasha: Edition World Cancer Research Fund/American Institute for Cancer Research, 1997: 670 pp.
9. Krishnaswamy K, Prasad MPR, Krishna TP, Annapurna VV, Amarendra Reddy G. A case study of nutrient intervention of oral precancerous lesions in India. Eur J Cancer B Oral Oncol 1995; 31B: 41-8.
10. Brigelius-Flohé R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 2002; 76:703-16.
11. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 334:1156-62.
12. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and risk of coronary heart disease in women. N Engl J Med 1993; 328: 1444-9.
13. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349:1715-20.
14. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, et al. Randomised controlled trial of viamin E in patients with coronary disease: Cambridge Heart Antioxydant Study (CHAOS). Lancet 1996; 347: 781-6.
15. GISSI-prevenzione investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet 1999; 354:447-55.
16. Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342:154-60.
17. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of antioxydant vitamin supplementation in 20536 high risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:23-33.
18. Eichholzer M, Stahelin HB, Gey KF, Ludin E, Bernasconi F. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 1996; 66:145-50.
19. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels results of a prospective analysis. Cancer Res 1999; 59:1225-30.
20. Tzonou A, Signorello LB, Lagiou P, Wuu J, Trichopoulos D, Trichopoulou A. Diet and cancer of the prostate: a case-control study in Greece. Int J Cancer 1999; 80:704-8.
21. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90:440-6.
22. Yong LC, Brown CC, Schatzkin A, Dresser CM, Slesinski MJ, Cox CS, et al. Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic follow up study. Am J Epidemiol 1997; 146:231-4.
23. Blot WJ, Li HY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidences, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85:1483-92.
24. Grievink L, Jansen SMA, Van'T Veer P, Brunekreef B. Acute effects of ozone on pulmonary function of cyclists receiving antioxydant supplements. Occup Environ Med 1998; 55:13-7.
25. Grievink L, Zijlstra AG, Ke X, Brunekreef B. Double-blind intervention trial on modulation of ozone effects on pulmonary function by antioxydant supplements. Am J Epidemiol 1999; 149:306-14.
26. Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, et al. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997; 66:803-9.
27. Perrig WJ, Perrig P, Stahelin HB. The relation between antioxydants and memory performance in the old and very old. J Am Geriatr Soc 1997; 45:718-24.
28. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. β-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999; 91:2102-6.
29. Cook NR, Lee IM, Manson JE, Buring JE, Hennekens CH. Effects of beta-carotene on cancer incidence by baseline characteristics in the Physicians' Health Study. Cancer Causes Control 2000; 11:617-26.
30. The alpha-tocopherol, beta-carotene cancer prevention study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-35.
31. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 1996; 88:1550-9.
32. IARC Handbooks of cancer prevention, Carotenoids, IARC, 1998.
33. Gerber M. Oxidative stress, antioxydants and cancer. In: Sen CK, Packer L, Hanninen O, editors. Exercise and oxygen toxicity. Amsterdam: Elsevier, 2000:927-50.
34. Saintot M, Mathieu-Daude H, Astre C, Grenier J, Simony-Lafontaine J, Gerber M. Oxidant-antioxidant status in relation to survival among breast cancer patients. Int J Cancer, 2002; 97:574-9.
35. Léger CL, Amiot-Carlin MJ. Polyphenols: an introduction. In: Agropolis, editor. Mediterranean diet and health. Current news and prospects. Paris: John Libbey, 2001:103-8.
36. Hertog MGL, Hollman PCH. Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr 1996; 50:63-71.
37. Nijveldt RJ, Van Nood E, Van Hoorn EC, Boelens PG, Norren K, Leeuwen PAM. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74:418-25.
38. Carbonneau MA, Leger CL, Monnier L, Bonnet C, Michel F, Fouret G, et al. Supplementation with red wine phenolics increases the antioxidant capacity of plasma and vitamin E of low density lipoprotein without changing the lipoprotein Cu2+-oxidability: possible explanation by phenolics location. Eur J Clin Nutr 1997; 51:682-90.
39. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidants, flavonoids and the risk of coronary heart disease: the Zutphen elderly study. Lancet 1993; 342:1007-11.
40. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 1996; 312:478-81.
41. Knekt P, Jarvinen R, Seppanen R, Heliovaara M, Teppo L, Pukkala E, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997; 146:223-30.
42. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN. Intake of flavonoids and lung cancer. J Natl Cancer Inst 2000; 92:154-60.
43. Gerber M, Boutron-Ruault MC, Hercberg S, Riboli E, Scalbert A, Siess MH. Actualités en cancérologie: fruits, légumes et cancers. Une synthèse du réseau Nacre. Bull Cancer 2002; 89:293-312.
44. Setchell KDR, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999; 129: 758S-67S.
45. Anderson JB, Anthony MS, Cline JM, Washburn SA, Garner SC. Health potential of soy isoflavones for menopausal women. Public Health Nutr 1999; 2:489-504.
46. Horcajada-Molteni MN, Coxam V. Flavonols and isoflavones prevent bone loss in the ovariectomized rat, a model for post-menopausal osteoporosis. In: Burckhardt F, editor. Nutritional aspects of osteoporosis. San Diego: Academic Press, 2001: 325-340